Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Yanai, H."" wg kryterium: Autor


Tytuł:
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
Autorzy:
Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Adachi H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Hakoshima M; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Iida S; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Katsuyama H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Mar 04; Vol. 13 (5). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cardiovascular Diseases*/drug therapy
Metabolic Syndrome*/drug therapy
Renal Insufficiency, Chronic*/drug therapy
Organic Anion Transporters*
Benzothiazoles*
Humans ; Rats ; Animals ; Uricosuric Agents/therapeutic use ; Uric Acid/metabolism ; Glucose
Czasopismo naukowe
Tytuł:
Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn's Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study.
Autorzy:
Hirsch A; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Scapa E; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Fliss-Isakov N; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Tulchinsky H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Department of Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Itzkowitz E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Department of Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Kariv Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Department of Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Ron Y; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Yanai H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4941492, Israel.
White I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Department of General Surgery, Rabin Medical Center, Petah-Tikva 4941492, Israel.
Yassin S; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Cohen NA; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Brazovski E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; The Pathology Department, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Dotan I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4941492, Israel.
Maharshak N; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Dec 10; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Anthropogenic Microparticles in Sea-Surface Microlayer in Osaka Bay, Japan.
Autorzy:
Zhou M; Graduate School of Maritime Sciences, Kobe University, Fukaeminami-machi, Higashinada-ku, Kobe 658-0022, Japan.
Yanai H; Graduate School of Maritime Sciences, Kobe University, Fukaeminami-machi, Higashinada-ku, Kobe 658-0022, Japan.
Yap CK; Graduate School of Maritime Sciences, Kobe University, Fukaeminami-machi, Higashinada-ku, Kobe 658-0022, Japan.; Department of Biology, Faculty of Science, Universiti Putra Malaysia, UPM Serdang, Serdang 43400, Selangor, Malaysia.
Emmanouil C; School of Spatial Planning and Development, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Okamura H; Research Center for Inland Seas, Kobe University, Fukaeminami-machi, Higashinada-ku, Kobe 658-0022, Japan.
Pokaż więcej
Źródło:
Journal of xenobiotics [J Xenobiot] 2023 Nov 07; Vol. 13 (4), pp. 685-703. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Autorzy:
Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Japan.
Adachi H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Japan.
Hakoshima M; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Japan.
Iida S; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Japan.
Katsuyama H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 23; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cardiovascular Diseases*/etiology
Cardiovascular Diseases*/therapy
Insulin Resistance*
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Fatty Liver*/metabolism
Atherosclerosis*/therapy
Atherosclerosis*/drug therapy
Humans ; PPAR alpha/metabolism ; Obesity/metabolism ; Fatty Acids/metabolism
Czasopismo naukowe
Tytuł:
Prescription of anti-influenza drugs in Japan, 2014-2020: A retrospective study using open data from the national claims database.
Autorzy:
Sako A; Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Gu Y; Department of Infectious Diseases, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Tokyo, Japan.
Masui Y; Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Yoshimura K; Center for Next Generation of Community Health, Chiba University Hospital, Chuo-ku, Chiba, Japan.
Yanai H; Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Ohmagari N; Disease Control and Prevention Center, Center Hospital, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 04; Vol. 18 (10), pp. e0291673. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza, Human*/drug therapy
Influenza, Human*/epidemiology
Male ; Humans ; Female ; Retrospective Studies ; Japan/epidemiology ; Prescriptions ; Insurance, Health
Czasopismo naukowe
Tytuł:
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Autorzy:
Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Adachi H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Hakoshima M; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Katsuyama H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 11; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hyperlipidemias*/diagnosis
Hyperlipidemias*/drug therapy
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Atherosclerosis*/diagnosis
Atherosclerosis*/drug therapy
Humans ; Lipoproteins ; Triglycerides ; Lipoproteins, VLDL ; Postprandial Period
Czasopismo naukowe
Tytuł:
Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data.
Autorzy:
Konikoff T; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Yanai H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Libchik D; Faculty of Agriculture, Food and Environment, Hebrew University of Jerusalem, Rehovot 7610001, Israel.
Avni-Biron I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Snir Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.
Banai H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.
Broytman Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.
Dotan I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Ollech JE; Division of Gastroenterology, Rabin Medical Center, Petah Tikva 4941492, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Jul 04; Vol. 12 (13). Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center.
Autorzy:
Avni Biron I; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Hayat L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Ollech JE; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Banai-Eran H; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Narkis B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Helen Schneider Hospital for Women, Rabin Medical Center, Petah-Tikva 4941492, Israel.
Houri O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Helen Schneider Hospital for Women, Rabin Medical Center, Petah-Tikva 4941492, Israel.
Pauker MH; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Shay V; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.
Dotan I; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Hadar E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Helen Schneider Hospital for Women, Rabin Medical Center, Petah-Tikva 4941492, Israel.
Yanai H; Inflammatory Bowel Disease Center, Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 4919001, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Jun 18; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Like a shot-through manubrium: A rare presentation of skeletal tuberculosis.
Autorzy:
Fujiwara T; Department of Orthopaedic Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama 700-8558 Japan.
Yanai H; Department of Diagnostic Pathology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama 700-8558 Japan.
Hagiya H; Department of General Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama 700-8558 Japan.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2023 May 01; Vol. 11 (5), pp. e7119. Date of Electronic Publication: 2023 May 01 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Tytuł:
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease.
Autorzy:
Ellul P; Division of Gastroenterology, Mater Dei hospital, Malta.
Schembri J; Division of Gastroenterology, Mater Dei hospital, Malta.
Vella Baldacchino A; Division of Gastroenterology, Mater Dei hospital, Malta.
Molnár T; Department of Medicine, Szent-Györgyi Albert Medical School, University of Szeged, Hungary.
Resal T; Department of Medicine, Szent-Györgyi Albert Medical School, University of Szeged, Hungary.
Allocca M; Gastroenterology and Endoscopy, IRCCS Hospital San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
Furfaro F; Gastroenterology and Endoscopy, IRCCS Hospital San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
Dal Buono A; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Theodoropoulou A; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece.
Fragaki M; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece.
Tsoukali E; Department of Gastroenterology, GHA 'Evangelismos-Polykliniki', Athens, Greece.
Mantzaris GJ; Department of Gastroenterology, GHA 'Evangelismos-Polykliniki', Athens, Greece.
Phillips FM; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Radford S; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Moran G; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Gonzalez H; Hull University Teaching Hospitals, Hull, UK.
Sebastian S; Hull University Teaching Hospitals, Hull, UK.
Fousekis F; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Christodoulou D; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Snir I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
Lerner Z; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
Yanai H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
Michalopoulos G; Gastroenterology Department, 'Tzaneion' General Hospital of Piraeus, Greece.
Tua J; Division of Gastroenterology, Mater Dei hospital, Malta.
Camilleri L; Faculty of Science, University of Malta, Malta.
Papamichael K; Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Karmiris K; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece.
Katsanos K; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2023 Apr 19; Vol. 17 (4), pp. 489-496.
Typ publikacji:
Journal Article
MeSH Terms:
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/therapy
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/therapy
Colorectal Neoplasms*/complications
Humans ; Male ; Retrospective Studies ; Prognosis ; Prospective Studies ; Neoplasm Recurrence, Local/complications ; Disease Progression ; Inflammation/complications
Czasopismo naukowe
Tytuł:
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
Autorzy:
Albshesh A; Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Ramat Gan 5262100, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.
Bannon L; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.; Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel-Aviv 6423906, Israel.
Sharar Fischler T; Rabin Medical Center, Division of Gastroenterology, Department of Gastroenterology, Petah Tikva 49100, Israel.
Truyens M; IBD Unit, Department of Gastroenterology, Ghent University Hospital, 9000 Ghent, Belgium.
Vavricka SR; Division of Gastroenterology and Hepatology, University Hospital, CH-8048 Zurich, Switzerland.
Tepes K; General Hospital Celje, 3000 Celje, Slovenia.
Pugliese D; IBD Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Savarino EV; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy.
Zittan E; Abraham and Sonia Rochlin IBD Unit, Department of Gastroenterology, Emek Medical Center, Afula 1834111, Israel.; Rappaport Faculty of Medicine Technion, Israel Institute of Technology, Haifa 3200003, Israel.
Drobne D; Department of Gastroenterology, University Medical Centre Ljubljana, 1231 Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, 1231 Ljubljana, Slovenia.
Roblin X; Service de Gastrologie-Entérologie-Hépatologie, CHU de Saint-Etienne, 42270 Saint-Etienne, France.
Bar-Gil Shitrit A; Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem 9103102, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9372212, Israel.
Armuzzi A; IBD Center, IRCCS Humanitas Research Hospital, Rozzano, 35128 Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
Lobaton T; IBD Unit, Department of Gastroenterology, Ghent University Hospital, 9000 Ghent, Belgium.
Maharshak N; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.; Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel-Aviv 6423906, Israel.
Yanai H; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.; Rabin Medical Center, Division of Gastroenterology, Department of Gastroenterology, Petah Tikva 49100, Israel.
Ben-Horin S; Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Ramat Gan 5262100, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.
Kopylov U; Sheba Medical Center, Department of Gastroenterology, Tel Hashomer, Ramat Gan 5262100, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 52621, Israel.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Mar 26; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Reversing the Bond Length Alternation Order in Conjugated Polyenes by Substituent Effects.
Autorzy:
Yanai H; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Terajima Y; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Kleemiss F; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, CH-3012, Bern, Switzerland.; Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, D-93053, Regensburg, Germany.
Grabowsky S; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, CH-3012, Bern, Switzerland.
Matsumoto T; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Pokaż więcej
Źródło:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2023 Mar 13; Vol. 29 (15), pp. e202203538. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Potential of HMGB-inhibitory oligodeoxynucleotide ISM ODN to neutrophil recruitment in mouse model of hepatitis.
Autorzy:
Inoue A; Department of Inflammology, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Chiba S; Department of Inflammology, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Eto S; Department of Inflammology, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Taniguchi T; Department of Inflammology, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Yanai H; Department of Inflammology, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło:
Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2023 Mar; Vol. 28 (3), pp. 202-210. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
HMGB1 Protein*/metabolism
Hepatitis*
Mice ; Animals ; Oligodeoxyribonucleotides/pharmacology ; Disease Models, Animal ; Neutrophil Infiltration
Czasopismo naukowe
Tytuł:
Risk for Prison-to-Community Tuberculosis Transmission, Thailand, 2017-2020.
Autorzy:
Miyahara R
Piboonsiri P
Chiyasirinroje B
Imsanguan W
Nedsuwan S
Yanai H
Tokunaga K
Palittapongarnpim P
Murray M
Mahasirimongkol S
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 Mar; Vol. 29 (3), pp. 477-483.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Tuberculosis*/diagnosis
Mycobacterium tuberculosis*/genetics
Humans ; Prisons ; Cohort Studies ; Thailand
Czasopismo naukowe
Tytuł:
Handgrip strength is inversely associated with augmentation index in patients with type 2 diabetes.
Autorzy:
Hamasaki H; Hamasaki Clinic, 2-21-4 Nishida, Kagoshima, 890-0046, Japan. h.
Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jan 20; Vol. 13 (1), pp. 1125. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Cardiovascular Diseases*
Humans ; Hand Strength/physiology ; Cross-Sectional Studies ; Muscle Strength/physiology
Czasopismo naukowe
Tytuł:
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
Autorzy:
Yanai H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Kagramanova A; Moscow Clinical Scientific Centre named after. A.S. Loginov, Moscow, Russian Federation.
Knyazev O; Moscow Clinical Scientific Centre named after. A.S. Loginov, Moscow, Russian Federation.; State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Moscow, Russian Federation.; Research Institute of Health Organization and Medical Management, Moscow, Russian Federation.
Sabino J; Department of Gastroenterology, University Hospitals of Leuven, Leuven, Belgium.
Haenen S; Department of Gastroenterology, University Hospitals of Leuven, Leuven, Belgium.
Mantzaris GJ; Department of Gastroenterology, GHA 'Evaggelismos-Ophthalmiatreion Athinon-Polykliniki', Athens, Greece.
Mountaki K; Department of Gastroenterology, GHA 'Evaggelismos-Ophthalmiatreion Athinon-Polykliniki', Athens, Greece.
Armuzzi A; IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Pugliese D; CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Furfaro F; IBD Center, Humanitas Research Hospital-IRCCS, Milan, Italy.
Fiorino G; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
Drobne D; Department of Internal Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.; Department of Gastroenterology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Kurent T; Department of Gastroenterology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Yassin S; Sackler Faculty of Medicine, Tel Aviv University, Israel.; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel.
Maharshak N; Sackler Faculty of Medicine, Tel Aviv University, Israel.; Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel.
Castiglione F; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
de Sire R; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Nardone OM; Department of Public Health, University of Naples Federico II, Naples, Italy.
Farkas K; Department of Medicine, University of Szeged, Szeged, Hungary.
Molnar T; Department of Medicine, University of Szeged, Szeged, Hungary.
Krznaric Z; Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre, Zagreb, Croatia.
Brinar M; Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre, Zagreb, Croatia.
Chashkova E; Irkutsk Scientific Center of Surgery and Traumatology, Russia.
Livne Margolin M; Sackler Faculty of Medicine, Tel Aviv University, Israel.; Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Kopylov U; Sackler Faculty of Medicine, Tel Aviv University, Israel.; Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Bezzio C; Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho (MI), Italy.
Bar-Gil Shitrit A; Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Lukas M; Clinical and Research Centre for Inflammatory Bowel Disease, ISCARE Clinical Centre, Prague, Czech Republic.; Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Chaparro M; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS- Princesa), Universidad Autónoma de Madrid (UAM), Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Truyens M; IBD unit, Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Nancey S; Department of Gastroenterology, Lyon-Sud hospital, Hospices Civils de Lyon, Lyon and INSERM U1111, CIRI, Lyon, France.
Lobaton T; IBD unit, Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Gisbert JP; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS- Princesa), Universidad Autónoma de Madrid (UAM), Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Saibeni S; Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho (MI), Italy.
Bacsúr P; Department of Medicine, University of Szeged, Szeged, Hungary.
Bossuyt P; Imelda GI clinical Research Center, Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium.
Schulberg J; Department of Gastroenterology, St Vincent's Hospital, Melbourne, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.; Department of Gastroenterology, Austin Hospital, Melbourne, VIC, Australia.
Hoentjen F; Inflammatory Bowel Disease Center, Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands and Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.
Viganò C; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Palermo A; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Torres J; Division of Gastroenterology, Hospital da Luz Lisboa, Portugal.; Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Lisbon, Portugal.
Revés J; Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Lisbon, Portugal.
Karmiris K; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece.
Velegraki M; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece.
Savarino E; Department of Surgical Oncological & Gastroenterological Sciences (DiSCOG), Gastroenterology Unit, Padua University, Padua, Italy.
Markopoulos P; Department of Gastroenterology, Metaxa Memorial General Hospital, Piraeus, Greece.
Tsironi E; Department of Gastroenterology, Metaxa Memorial General Hospital, Piraeus, Greece.
Ellul P; Division of Gastroenterology Mater Dei Hospital, Msida, Malta.
Calviño Suárez C; Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Weisshof R; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, The Technion - Israel Institute of Technology, Haifa, Israel.
Ben-Hur D; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, The Technion - Israel Institute of Technology, Haifa, Israel.
Naftali T; Institute of Gastroenterology, Meir Hospital Sapir Medical Center, Kfar Saba, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Eriksson C; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Koutroubakis IE; Gastroenterology Department, University Hospital of Heraklion, Crete, Greece.
Foteinogiannopoulou K; Gastroenterology Department, University Hospital of Heraklion, Crete, Greece.
Limdi JK; Department of Gastroenterology, The Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences, University of Manchester, Manchester, UK.
Liu E; Department of Gastroenterology, The Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences, University of Manchester, Manchester, UK.
Surís G; Gastroenterology Department, Hospital de Bellvitge and IDIBELL, L'Hospitalet, Spain.
Calabrese E; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.
Zorzi F; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.
Filip R; Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, Rzeszów, Poland.
Ribaldone DG; Department of Medical Sciences, University of Turin, Turin, Italy.
Snir Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Goren I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Banai-Eran H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Broytman Y; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Amir Barak H; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Avni-Biron I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Ollech JE; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Dotan I; Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Aharoni Golan M; Department of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Concord Medical Center, Clalit Health Services, Bnei Brak, Israel.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2022 Dec 05; Vol. 16 (12), pp. 1882-1892.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Biological Products*/therapeutic use
Crohn Disease*/drug therapy
Crohn Disease*/prevention & control
Crohn Disease*/surgery
Adult ; Female ; Humans ; Male ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Ustekinumab/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł:
Newly Diagnosed Crohn's Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts.
Autorzy:
Goren I; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Sharar Fischler T; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.
Yanai H; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.
Pal P; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad 501301, India.
Adigopula B; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad 501301, India.
Pendyala S; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad 501301, India.
Ganesh G; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad 501301, India.
Vishnubhotla R; Department of Genomics and Molecular Biology, Institute of Translational Research, Asian Institute of Gastroenterology and AIG Hospitals, Hyderabad 500032, India.
Rabinowitz KM; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.; Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Hospital Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49414, Israel.
Shaham Barda E; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.; Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Hospital Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49414, Israel.
Yadamreddy D; Department of Genomics and Molecular Biology, Institute of Translational Research, Asian Institute of Gastroenterology and AIG Hospitals, Hyderabad 500032, India.
Godny L; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.
Peleg N; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.
Banerjee R; Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad 501301, India.
Dotan I; IBD Center, Division of Gastroenterology, Rabin Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49100, Israel.
Pokaż więcej
Corporate Authors:
Indo-Israeli IBD GastroEnterology Partnership (TIIIGER)
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Nov 22; Vol. 11 (23). Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk.
Autorzy:
Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Chiba 272-8516, Japan.
Adachi H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Chiba 272-8516, Japan.
Hakoshima M; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Chiba 272-8516, Japan.
Katsuyama H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Chiba 272-8516, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Nov 04; Vol. 23 (21). Date of Electronic Publication: 2022 Nov 04.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Cardiovascular Diseases*/drug therapy
Insulin Resistance*
Atherosclerosis*/drug therapy
Diabetes Mellitus*/drug therapy
Humans ; Cholesterol, LDL ; Lipoproteins ; Obesity/drug therapy ; Risk Factors
Czasopismo naukowe
Tytuł:
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study.
Autorzy:
Avni-Biron I; IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mishael T; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Zittan E; Institute of Gastroenterology and Liver Diseases, IBD Unit, Emek Medical Center, Afula, Israel.
Livne-Margolin M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Institute of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Zinger A; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Gastroenterology, Hadassah Medical Center, Jerusalem, Israel.
Tzadok R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel.
Goldenberg R; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Kopylov U; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Institute of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel.
Ron Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel.
Hadar E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Maternal fetal medicine, Helen Schneider hospital of women, Rabin Medical Center, Petah Tikva, Israel.
Helman S; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Granovsky SG; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Ollech JE; IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Arazi A; Institute of Gastroenterology and Liver Diseases, IBD Unit, Emek Medical Center, Afula, Israel.
Farkash R; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Pauker MH; IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
Yanai H; IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Dotan I; IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shitrit AB; IBD MOM Unit, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (9), pp. 1361-1369. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Biological Products*
Inflammatory Bowel Diseases*/drug therapy
Chronic Disease ; Female ; Humans ; Infant, Newborn ; Mesalamine ; Pregnancy ; Prospective Studies ; Tumor Necrosis Factor Inhibitors ; Ustekinumab/adverse effects
Czasopismo naukowe
Tytuł:
Behavioral factors associated with SARS-CoV-2 infection in Japan.
Autorzy:
Arashiro T; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Arima Y; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Muraoka H; CLINIC FOR Tamachi, Tokyo, Japan.
Sato A; KARADA Internal Medicine Clinic, Tokyo, Japan.
Oba K; Department of Pediatrics, Showa General Hospital, Tokyo, Japan.
Uehara Y; Department of Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Arioka H; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.
Yanai H; Department of Clinical Laboratory, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Yanagisawa N; Yanagisawa Clinic, Tokyo, Japan.
Nagura Y; Shinjuku Home Clinic, Tokyo, Japan.
Kato Y; Department of Infectious Diseases, Graduate School of Medicine, International University of Health and Welfare, Chiba, Japan.
Kato H; Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan.
Ueda A; Department of Infectious Diseases, Japanese Red Cross Medical Center, Tokyo, Japan.
Ishii K; Saitama Sekishinkai Hospital, Saitama, Japan.
Ooki T; Saitama Sekishinkai Hospital, Saitama, Japan.
Oka H; Department of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
Nishida Y; Department of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
Stucky A; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Miyahara R; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Smith C; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Hibberd M; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Ariyoshi K; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Suzuki M; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Sep; Vol. 16 (5), pp. 952-961. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Adult ; COVID-19 Testing ; Case-Control Studies ; Humans ; Japan/epidemiology ; SARS-CoV-2 ; Travel ; Travel-Related Illness
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies